Labcorp acquires MLM Medical Labs in global expansion
Article excerpt
Buying MLM gives Labcorp a wholly owned laboratory network that spans North America, Europe, Asia and Africa. MLM has labs in Memphis and Mönchengladbach, Germany, plus a subsidiary called Cytespace Africa Laboratories in South Africa. The company, which was originally based in Mönchengladbach, acquired the Memphis site in its 2020 takeover of CirQuest Labs and added further U.S. capacity by buying MD Biosciences later that year. MLM bought Cytespace last year to add capacity in Africa. Using the global footprint, MLM creates and validates laboratory developed tests to support specialized clinical and translational research. The capabilities overlap with the central laboratory infrastructure that Labcorp has built up through deals such as its $6.1 billion takeover of Covance. Buying MLM gives Labcorp a wholly owned laboratory network that spans North America, Europe, Asia and Africa, where the acquired company runs the first fully CAP-accredited central lab. Labcorp also named MLM’s scientific and regulatory expertise, as well as its biomarker and specialty testing capabilities, as drivers of the deal, noting that they equip it to support complex clinical trial programs. Labcorp spent $528.6 million, net of cash acquired, on takeovers in the first half of 2026. In late June, Labcorp agreed to pay a further $155 million for select assets of an outreach laboratory services...
Keep reading with a free account
The rest of this article, and every signal for Labcorp, is in your free account.
Extracted from this sentence
In the second quarter, the company acquired Parkview Health assets in Indiana and Ohio, and expanded in Oklahoma and Texas by buying Tribal Diagnostics.
